Alivus Life Sciences Limited (BOM:543322)
India · Delayed Price · Currency is INR 1,348.60
-21.60 (-1.58%)
At close: Aug 21, 2026
Alivus Life Sciences Market Cap
Alivus Life Sciences has a market cap or net worth of 165.81 billion as of August 21, 2026. Its market cap has increased by 39.90% in one year.
Market Cap
165.81B
Enterprise Value
158.55B
Revenue
25.90B
Ranking
n/a
PE Ratio
27.50
Stock Price
1,348.60
ChartMarket Cap Chart
Since August 6, 2021, Alivus Life Sciences's market cap has increased from 91.71B to 165.81B, an increase of 80.79%. That is a compound annual growth rate of 12.46%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 165.81B | 47.45% |
| Dec 31, 2025 | 112.45B | -6.68% |
| Dec 31, 2024 | 120.50B | 49.68% |
| Dec 29, 2023 | 80.51B | 56.38% |
| Dec 30, 2022 | 51.48B | -33.42% |
| Dec 31, 2021 | 77.32B | -15.69% |
| Aug 6, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Neuland Laboratories | 298.87B |
| Shilpa Medicare | 159.30B |
| Suven Life Sciences | 98.21B |
| IOL Chemicals and Pharmaceuticals | 49.77B |
| Gujarat Themis Biosyn | 41.50B |
| Sai Parenteral's | 23.89B |
| NGL Fine-Chem | 18.28B |
| Bajaj HealthCare | 10.84B |